Masood Naseripour - Concepedia

Author

Masood Naseripour

Iran University of Medical Sciences ORCID

Also Known As

Ahad Sedaghat, KhalilGhasemi Falavarjani, M Naseripour, M. Naseripour, MASOOD NASERIPOUR, Masood Naseripour, Masoud Naseripour, Naseripour Masood

121

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Iran University of Medical Sciences Rasool Akram Hospital Tehran University of Medical Sciences Wills Eye Hospital Thomas Jefferson University

About

Masood Naseripour is an author at Iran University of Medical Sciences specializing in ophthalmology, medicine, and glaucoma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	18	928
2	Engineering	2	2	102
3	Health Sciences	2	2	32
4	Biomedical Engineering	2	2	102
5	Public Health	1	1	22

Masood Naseripour

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma Carol L. Shields, Masood Naseripour, Jerry A. Shields American Journal of Ophthalmology Topical Mitomycin COphthalmologyGlaucomaDermatologyOcular Pathology	2002	179
Plaque radiotherapy for large posterior uveal melanomas (≥8-mm thick) in 354 consecutive patients 11Presented in part at the annual meeting of the American Academy of Ophthalmology, October 2002. Carol L. Shields, Masood Naseripour, Jacqueline Cater, Ophthalmology Consecutive PatientsOphthalmologyRadiation TherapyMelanomaOctober 2002	2002	178
Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma Carol L. Shields, Masood Naseripour, Jerry A. Shields, Ophthalmology Pagetoid InvasionTopical Mitomycin-cOphthalmologyOculoplasticsSurgical Pathology	2002	140
Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications Carol L. Shields, Masood Naseripour, Jerry A. Shields, American Journal of Ophthalmology Custom-designed Plaque RadiotherapyOphthalmologyTumor ControlMelanomaGlaucoma	2003	105
Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival Masood Naseripour, Haji Mohammad Nazari, Pejman Bakhtiari, British Journal of Ophthalmology	2008	90
Nanogel-based natural polymers as smart carriers for the controlled delivery of Timolol Maleate through the cornea for glaucoma Roya Ilka, Mojdeh Mohseni, Mehran Kianirad, International Journal of Biological Macromolecules NanomedicineSmart CarriersEngineeringOphthalmologyNanogel-based Natural Polymers	2017	88
Intravitreal Injection of Bevacizumab before Vitrectomy for Proliferative Diabetic Retinopathy Mehdi Modarres, Nazari Hossein, Khalil Ghasemi Falavarjani, European Journal of Ophthalmology	2009	78
“Retinoblastoma survival disparity”: The expanding horizon in developing countries Masood Naseripour Saudi Journal of Ophthalmology	2012	59
Bilateral Pseudomonas aeruginosa endophthalmitis following bilateral simultaneous cataract surgery Mohsen Bahmani Kashkouli, Shabnam Salimi, Hossein Aghaee, Indian Journal of Ophthalmology Bilateral Visual LossOphthalmic SurgeryVitreous BodyOphthalmologyMedicine	2007	54
INTRAVITREAL INJECTION OF 2.5 mg VERSUS 1.25 mg BEVACIZUMAB (AVASTIN) FOR TREATMENT OF CNV ASSOCIATED WITH AMD Mehdi Modarres, Masood Naseripour, Khalil Ghasemi Falavarjani, Retina	2009	54

Page 1